Artwork

Contenu fourni par Mentored. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mentored ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Fighting Antibiotic Resistance: Going Public w James Graham

37:15
 
Partager
 

Manage episode 415111490 series 1511965
Contenu fourni par Mentored. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mentored ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

With Stake, Australia's leading investing platform, I'm excited to share the ninth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.


This podcast will delve into the journey of James Graham, one of the youngest CEOs in Australia's public company sector. At 34, James leads Recce Pharmaceuticals (ASX:RCE), a rapidly growing medical technology firm taking on antibiotic resistance, a global health crisis.


We explore the highs and lows of building a biotech company, the road to going public, and the impact of Recce's novel approach to fighting infectious diseases. Get insights into James' journey from startup entrepreneur to industry leader, his perspectives on global health, and his vision for making a lasting impact.


In 2016, Recce was listed on the Australian Securities Exchange with the stock ticker RCE.


DISCLAIMER:

Views expressed are those of the individual only. This does not constitute financial advice.

You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj.

Join the Facebook Group.

Follow Mark Bouris on Instagram, LinkedIn & YouTube.

See omnystudio.com/listener for privacy information.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

455 episodes

Artwork
iconPartager
 
Manage episode 415111490 series 1511965
Contenu fourni par Mentored. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mentored ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

With Stake, Australia's leading investing platform, I'm excited to share the ninth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.


This podcast will delve into the journey of James Graham, one of the youngest CEOs in Australia's public company sector. At 34, James leads Recce Pharmaceuticals (ASX:RCE), a rapidly growing medical technology firm taking on antibiotic resistance, a global health crisis.


We explore the highs and lows of building a biotech company, the road to going public, and the impact of Recce's novel approach to fighting infectious diseases. Get insights into James' journey from startup entrepreneur to industry leader, his perspectives on global health, and his vision for making a lasting impact.


In 2016, Recce was listed on the Australian Securities Exchange with the stock ticker RCE.


DISCLAIMER:

Views expressed are those of the individual only. This does not constitute financial advice.

You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj.

Join the Facebook Group.

Follow Mark Bouris on Instagram, LinkedIn & YouTube.

See omnystudio.com/listener for privacy information.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

455 episodes

Tous les épisodes

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide